Table 1.

Phase I: patient’s characteristics.

Patient’s Characteristics	Nab-FOLFIRI (Arm A)		Nab-FOLFOX (Arm B)
	N	%	N	%
Sex
Male	15	56	14	39
Female
Age, years
Median	62		60
Range	(38–75)		(42–74)
ECOG
0	19	70	23	64
1	8	30	13	36
Prior adjuvant therapy
Yes	2	7	4	11
No	25	93	32	89
Prior surgery on primary
Yes	7	26	9	25
No	20	74	27	75
Tumor localization
Head	14	52	15	42
Neck–body	13	48	21	58
No. of metastatic sites
1	6	22	17	47
2	12	44	15	42
≥3	9	34	4	11
Site of metastatic disease
Liver	20	74	28	78
Lung	8	30	9	25
Lymph nodes	18	49	16	45
Peritoneum	6	22	8	22
Other	5	19	0	0
Biliary stenting
Yes	5	19	4	11
No	22	81	32	89
Ca 19.9 baseline
Median	68.3		336.5
Range	(0.95–41,251)		(0.80–136,505)